Compare Indofarma Tbk. (INAF) vs Nitrasanata Dharma Tbk. (JECX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Indofarma Tbk. vs Nitrasanata Dharma Tbk. — how do they compare? Indofarma Tbk. trades at Rp126 (market cap 390.51B), while Nitrasanata Dharma Tbk. trades at Rp1,340 (market cap 4.39T, 1.83M 24h volume). The key difference: Nitrasanata Dharma Tbk. is far larger — about 11.2× Indofarma Tbk.'s market cap. Which is the better fit depends on your goals.
| INAF | JECX | |
|---|---|---|
Market Cap | 390.51B | 4.39T |
Volume | — | 1.83M |
Lot | — | 18.28K |
Turnover | — | 2.42B |
Average Price | — | 1,326.31 |
Value | — | 2.42B |
Indicative Equilibrium Price | — | 1,340 |
Indicative Equilibrium Volume | — | 201 |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Indofarma Tbk.
PT Indonesia Farma Tbk, known as PT Indofarma (Persero) Tbk (the Company) was established based on Deed No. 1 dated January 2, 1996 as amended by Deed No. 134 dated January 26, 1996 both of Notary Sutjipto, SH. PT. Indofarma, Tbk began as medicine factory well known as "Pabrik Obat Manggarai". Then take over by Japan's Government from Nederland's Government on 1942. On 1950 the Indonesian Government acquisited the factory by Department of Health and functioned as center of pharmacy production for its department. On 1979 the name changed to be Department of Health Center of Pharmacy Production as non Profit institution as main assignment to produced medicine for public service. Then the Company changed the name as PT. Indonesia Farma Tbk, known as PT Indofarma (Persero) Tbk.
Read more on INAF →About Nitrasanata Dharma Tbk.
PT Nitrasanata Dharma Tbk (the Company) was established based on Notarial Deed No. 526 of Richardus Nangkih Sinulingga, S.H., dated November 28, 1990. The Company started its commercial operations in 1990. PT Magna Selaras Lestari is the controlling entity of the Company, and Dr. Darwan Madja Purba, SpM(K) as ultimate beneficial owner of the Company.
Read more on JECX →
